Community post

Cytophage, a Canadian phage biotech, recently made its debut on the Toronto Stock Exchange (TSX), and just announced that they’ve completed R&D on their OvaPhage product, to be sprayed over chicken eggs to reduce Salmonella, Escherichia, and Shigella. They are preparing to conduct field trials in Canada as a final step before commercialization.